|
1
|
Ng SB, Yan J, Huang G, Selvarajan V, Tay
JL, Lin B, Bi C, Tan J, Kwong YL, Shimizu N, et al: Dysregulated
microRNAs affect pathways and targets of biologic relevance in
nasal-type natural killer/T-cell lymphoma. Blood. 118:4919–4929.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SJ, Jung HA, Chuang SS, Hong H, Guo
CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, et al: Asia Lymphoma
Study Group: Extranodal natural killer/T-cell lymphoma involving
the gastrointestinal tract: Analysis of clinical features and
outcomes from the Asia Lymphoma Study Group. J Hematol Oncol.
6:862013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cook DR, Rossman KL and Der CJ: Rho
guanine nucleotide exchange factors: Regulators of Rho GTPase
activity in development and disease. Oncogene. 33:4021–4035. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang S, Li S, Yang X, Yang S, Liu S, Liu B
and Liu J: Elevated expression of T-lymphoma invasion and
metastasis inducing factor 1 in squamous-cell carcinoma of the head
and neck and its clinical significance. Eur J Cancer. 50:379–387.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu H, Shi G, Liu X, Wu H, Fan Q and Wang
X: Overexpression of Tiam1 predicts poor prognosis in patients with
esophageal squamous cell carcinoma. Oncol Rep. 25:841–848.
2011.PubMed/NCBI
|
|
7
|
Jin H, Li T and Ding Y, Deng Y, Zhang W,
Yang H, Zhou J, Liu C, Lin J and Ding Y: Methylation status of
T-lymphoma invasion and metastasis 1 promoter and its
overexpression in colorectal cancer. Hum Pathol. 42:541–551. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du X, Wang S, Lu J, Wang Q, Song N, Yang
T, Dong R, Zang L, Yang Y, Wu T and Wang C: Clinical value of
Tiam1-Rac1 signaling in primary gallbladder carcinoma. Med Oncol.
29:1873–1878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao L, Liu Y, Sun X, He M and Ding Y:
Overexpression of T lymphoma invasion and metastasis 1 predict
renal cell carcinoma metastasis and overall patient survival. J
Cancer Res Clin Oncol. 137:393–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi Y, Huang B, Yu L, Wang Q, Lan G and
Zhang Q: Prognostic value of Tiam1 and Rac1 overexpression in
nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec.
71:163–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding Y, Chen B, Wang S, Zhao L, Chen J,
Ding Y, Chen L and Luo R: Overexpression of Tiam1 in hepatocellular
carcinomas predicts poor prognosis of HCC patients. Int J Cancer.
124:653–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Engers R, Mueller M, Walter A, Collard JG,
Willers R and Gabbert HE: Prognostic relevance of Tiam1 protein
expression in prostate carcinomas. Br J Cancer. 95:1081–1086. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhong D, Li Y, Peng Q, Zhou J, Zhou Q,
Zhang R and Liang H: Expression of Tiam1 and VEGF-C correlates with
lymphangiogenesis in human colorectal carcinoma. Cancer Biol Ther.
8:689–695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao-Hong, Shibayama-Imazu T, Masuda Y,
Shinki T, Nakajo S and Nakaya K: Involvement of Tiam1 in apoptosis
induced by bufalin in HeLa cells. Anticancer Res. 27:245–249.
2007.PubMed/NCBI
|
|
15
|
Minard ME, Ellis LM and Gallick GE: Tiam1
regulates cell adhesion, migration and apoptosis in colon tumor
cells. Clin Exp Metastasis. 23:301–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adam L, Vadlamudi RK, McCrea P and Kumar
R: Tiam1 overexpression potentiates heregulin-induced lymphoid
enhancer factor-1/β-catenin nuclear signaling in breast cancer
cells by modulating the intercellular stability. J Biol Chem.
276:28443–28450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Engers R, Springer E, Michiels F, Collard
JG and Gabbert HE: Rac affects invasion of human renal cell
carcinomas by upregulating tissue inhibitor of metalloproteinases
(TIMP)-1 and TIMP-2 expression. J Biol Chem. 276:41889–41897. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bourguignon LY, Zhu H, Shao L and Chen YW:
Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic
breast tumor cell invasion and migration. J Cell Biol. 150:177–191.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissue (4th). Lyon, France:
IARC Press. 179–350. 2008.
|
|
20
|
Bierman PJ, Harris N and Armitage JO:
Non-Hodgkin's lymphoma. Cecil Medicine. Goldman L and Ausiello D:
(23rd). (Philadelphia). Saunders Elsevier. 1408–1425. 2008.
|
|
21
|
Komabayashi Y, Kishibe K, Nagato T, Ueda
S, Takahara M and Harabuchi Y: Downregulation of miR-15a due to
LMP1 promotes cell proliferation and predicts poor prognosis in
nasal NK/T-cell lymphoma. Am J Hematol. 89:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang HB, Zhan R, Wu SQ, Xu ZZ and Fan LP:
Expression of MCL-1 and microRNA-29a in extranodal NK/T-cell
lymphoma tissue. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 21:95–98.
2013.(In Chinese). PubMed/NCBI
|
|
23
|
Motsch N, Alles J, Imig J, Zhu J, Barth S,
Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, et al:
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell
lymphomas by deep sequencing. PLoS One. 7:e421932012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ti HJ, Nong L, Wang W, Zhang S and Li T:
Expression of microRNA in extranodal NK/T cell lymphoma, nasal
type. Zhonghua Bing Li Xue Za Zhi. 40:610–615. 2011.(In Chinese).
PubMed/NCBI
|
|
25
|
Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM,
Heo DS and Kim CW: MicroRNA-146a downregulates NFκB activity via
targeting TRAF6 and functions as a tumor suppressor having strong
prognostic implications in NK/T cell lymphoma. Clin Cancer Res.
17:4761–4771. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo
D, Yang F, Wei J, Wang L, Dykxhoorn DM, et al: MicroRNA-10A* and
MicroRNA-21 modulate endothelial progenitor cell senescence via
suppressing high-mobility group A2. Circ Res. 112:152–164. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohuchida K, Mizumoto K, Lin C, Yamaguchi
H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M and
Tanaka M: MicroRNA-10a is overexpressed in human pancreatic cancer
and involved in its invasiveness partially via suppression of the
HOXA1 gene. Ann Surg Oncol. 19:2394–2402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan Y, Zhang B, Wu T, Skogerbø G, Zhu X,
Guo X, He S and Chen R: Transcriptional inhibiton of Hoxd4
expression by miRNA-10a in human breast cancer cells. BMC Mol Biol.
10:122009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grady WM, Parkin RK, Mitchell PS, Lee JH,
Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz
AM, et al: Epigenetic silencing of the intronic microRNA
hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene.
27:3880–3888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haapa-Paananen S, Chen P, Hellström K,
Kohonen P, Hautaniemi S, Kallioniemi O and Perälä M: Functional
profiling of precursor MicroRNAs identifies MicroRNAs essential for
glioma proliferation. PLoS One. 8:e609302013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Buffa FM, Camps C, Winchester L, Snell CE,
Gee HE, Sheldon H, Taylor M, Harris AL and Ragoussis J:
MicroRNA-associated progression pathways and potential therapeutic
targets identified by integrated mRNA and microRNA expression
profiling in breast cancer. Cancer Res. 71:5635–5645. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu L, Liang YN, Luo XQ, Liu XD and Guo HX:
Association of miRNAs expression profiles with prognosis and
relapse in childhood acute lymphoblastic leukemia. Zhonghua Xue Ye
Xue Za Zhi. 32:178–181. 2011.(In Chinese). PubMed/NCBI
|
|
34
|
Ballabio E, Mitchell T, van Kester MS,
Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D,
Saunders NJ, et al: MicroRNA expression in Sezary syndrome:
Identification, function, and diagnostic potential. Blood.
116:1105–1113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Y, Li XF, Yang JH, Liao XY and Chen YZ:
microRNAs expression profile in acute promyelocytic leukemia cell
differentiation induced by all-trans retinoic acid and arsenic
trioxide. Zhonghua Xue Ye Xue Za Zhi. 33:546–551. 2012.(In
Chinese). PubMed/NCBI
|
|
36
|
Leivonen SK, Sahlberg KK, Mäkelä R, Due
EU, Kallioniemi O, Børresen-Dale AL and Perälä M: High-throughput
screens identify microRNAs essential for HER2 positive breast
cancer cell growth. Mol Oncol. 8:93–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu
R, Pan Z, Kang T and Huang W: MicroRNA-342 inhibits colorectal
cancer cell proliferation and invasion by directly targeting DNA
methyltransferase 1. Carcinogenesis. 32:1033–1042. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He YJ, Wu JZ, Ji MH, Ma T, Qiao EQ, Ma R
and Tang JH: miR-342 is associated with estrogen receptor-α
expression and response to tamoxifen in breast cancer. Exp Ther
Med. 5:813–818. 2013.PubMed/NCBI
|
|
39
|
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET,
Aprelikova O, Choi IJ, Munroe DJ and Green JE: miRNA signature
associated with outcome of gastric cancer patients following
chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu S, Huang S, Ding J, Zhao Y, Liang L,
Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1
expression by directly targeting its 3 untranslated region.
Oncogene. 29:2302–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
